1. | justaflicker | |
2. | marketpulse01 | |
3. | IttyBitty | |
4. | bob4033 |
1. | justaflicker | |
2. | marketpulse01 | |
3. | IttyBitty | |
4. | bob4033 |
1. | marketpulse01 09/29/2017 A bunch in next couple qtr's for {Link} |
2. | marketpulse01 01/16/2018 NEWS, - Oppenheimer Slashes Price Target on Eiger Biopharmaceuticals Inc (EIGR) Following Clinical Failure in PAH, But Remains Bullish - Smarter Analyst |
3. | justaflicker 01/16/2018 Cant believe this used to be a $400 stock in 2015 |
4. | IttyBitty 05/18/2018 Eiger (EIGR) Successfully Licensed Rights to Progeria; Wedbush Boosts Price Target |
5. | IttyBitty 09/29/2017 Makes Strategic Move {Link} |
6. | marketpulse01 10/23/2017 Great results, think it should head at least back to the 20s |
7. | marketpulse01 05/14/2018 Eiger BioPharmaceuticals Reports First Quarter 2018 Financial Results |
8. | bob4033 01/16/2018 Lower. Closed at its low |
9. | bob4033 03/22/2018 Details positive FDA guidance from a face to face discussion on the Hepatitis Delta Virus program in Februar… |
10. | justaflicker 04/26/2018 Wedbush reiterates Outperform rating, $36 PT |